نتایج جستجو برای: reactogenicity

تعداد نتایج: 566  

Journal: :Trials 2007
Eusebio V Macete Jahit Sacarlal John J Aponte Amanda Leach Margarita M Navia Jessica Milman Caterina Guinovart Inacio Mandomando Yolanda López-Púa Marc Lievens Alex Owusu-Ofori Marie-Claude Dubois Conor P Cahill Marguerite Koutsoukos Marla Sillman Ricardo Thompson Filip Dubovsky W Ripley Ballou Joe Cohen Pedro L Alonso

BACKGROUND Previous trials of the RTS, S malaria candidate vaccine have shown that this vaccine is safe, tolerated and immunogenic. The development plan for this vaccine aims at administering it in the first year of life through the Expanded Program on Immunization (EPI). The objective was to evaluate the safety and reactogenicity of RTS, S/AS02D (0.5 ml dose), a pediatric formulation of GlaxoS...

Journal: :Canadian journal of public health = Revue canadienne de sante publique 2017
Alaa Badawi Maria Shering Shusmita Rahman L Robbin Lindsay

BACKGROUND Lyme borreliosis (LB) is the most prevalent arthropod-borne infectious disease in North America. Currently, no vaccine is available to prevent LB in humans, although monovalent and multivalent vaccines have been developed in the past. OBJECTIVE The aim of the current study is to conduct a systematic review and meta-analysis to evaluate and compare the findings from these two classe...

2013
Tran Ngoc Huu Nguyen Trong Toan Ha Manh Tuan Ho Lu Viet Pham Le Thanh Binh Ta-Wen Yu Fakrudeen Shafi Ahsan Habib Dorota Borys

BACKGROUND Pneumococcal infections are major causes of child mortality and morbidity worldwide and antibiotic resistance of Streptococcus pneumoniae is a major concern, especially in Asian countries. The present study was designed to evaluate the reactogenicity and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered...

2012
Xavier Duval Adrian Caplanusi Henri Laurichesse Dominique Deplanque Pierre Loulergue Tejaswini Vaman Odile Launay Paul Gillard

BACKGROUND Flexibility of vaccination schedule and lower antigen content can facilitate pandemic vaccine coverage. We assessed the immune response and safety of AS03-adjuvanted A/California/7/2009 H1N1 pandemic vaccine containing half of the registered adult haemagglutinin (HA) antigen content, administered as a two-dose schedule at intervals of 21 days or 6 months in both young and elderly adu...

2014
Varsha K Jain Vijayalakshmi Chandrasekaran Long Wang Ping Li Aixue Liu Bruce L Innis

BACKGROUND An inactivated quadrivalent influenza vaccine (QIV) was recently licenced in the US as a thimerosal-free formulation presented in a pre-filled syringe. A multidose presentation is preferred in some settings due to reduced acquisition and cold storage costs. We assessed the immunogenicity and safety of a thimerosal-containing QIV formulated using a new manufacturing process for presen...

Journal: :Revista peruana de investigación en salud 2022

Objective. To evaluate the reactogenicity of SPUTNIK V vaccine in post-vaccinated 6th year Medicine students who carry out their care practices Autonomous Teaching Service Central Hospital Maracay-Venezuela. Period February 2021- 2022. Materials and methods. Prospective, evaluative, cross-sectional study. were recruited, between 21 35 years age carried internships Maracay. The most important st...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید